Shots: The companies expanded the collaboration to improve health for people with T2D. The agreement integrates the Dexcom G6 CGM system and Welldoc’s BlueStar digital health solution as a single platform offering The focus of the agreement is to empower users to take control of… Read More »Welldoc Expands their Partnership with Dexcom to Offer Type 2 Diabetes Management Solution
Birju Shah, Head of Product for Uber Health & Communities Nick Jordan, Founder and CEO, Narrative In a world where technology and Big Data can provide us with instantaneous access to our banking transactions, and our financial information and credit reports can be retrieved with a… Read More »COVID Exposed The Dire Need for Real-Time Healthcare Data Sharing
Dexcom launched its first venture fund. The company, which makes continuous glucose monitors, plans to invest in glucose sensing technologies and metabolic monitoring.
Shots: The companies reported that joint Livongo for diabetes and dexcom members will now receive CGM-powered insights that enables members to easily visualize their health information and understand how lifestyle decisions affect their blood glucose levels In Oct’2020, Teldoc merges with Livongo while in Jan’2020… Read More »Teladoc Health and Dexcom Offers CGM-Powered Insight for T2D
What You Should Know: – Teladoc Health and Dexcom announced an expanded partnership on a new offering measures the impact of continuous glucose monitoring and real-time health recommendations for people with Type 2 diabetes at no cost. Teladoc Health, Inc., the first and only comprehensive… Read More »Teladoc Health, Dexcom Offers CGM-Powered insights to People with Type 2 Diabetes
What You Should Know: – The digital diabetes market is on track to reach $1.5 billion dollars by 2024, according to a new report by Research2Guidance. – The confident growth of digital diabetes care will be driven by the growth of the global addressable market for digital… Read More »Digital Diabetes Market to Reach $1.5B by 2024, Research Finds
Shots: The companies will partner to promote Lyumjev (insulin lispro-aabc injection, 100 & 200 units/mL) with Dexcom G6 CGM to aid HCPs in the US for the management of diabetes, including giving visibility to the benefits of a new mealtime insulin HCPs treating T1D &… Read More »Eli Lilly Collaborates with Dexcom for Diabetes Management
What You Should Know: – Current Health has partnered with Dexcom to add continuous glucose monitoring (CGM) capabilities to its remote patient monitoring (RPM) platform – enhancing care and improving outcomes for diabetics. – Dexcom CGM data will transmit directly into the Current Health wearable… Read More »Current Health, Dexcom Partner to Deliver Continuous, Remote Glucose Monitoring
The company is rolling out Level2, a digital health program for patients with type 2 diabetes. It uses wearable devices and coaches to help users manage their health.